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Modern cancer chemotherapy may be said to have begun with the introduction of the nitrogen mustards towards the end of the Second World War. In the two decades which have followed, many thousands of compounds have been elaborated and screened for their action against malignant tumours. Unfortunately, there is as yet no cytotoxic agent which fulfils the cardinal requirement for the treatment of generalized cancer, namely, the ability to eradicate the malignant cell without irreparably damaging the patient.
An accident in 1950 gave Klopp of Washington the idea that the results of chemotherapy might be improved in the case of localized tumours by injection of agents directly into the artery supplying the part (Klopp et al. 1950) . He had observed a patient who had received a misplaced injection of nitrogen mustard into the brachial artery instead of the antecubital vein. A severe reaction occurred in the forearm and hand with erythema, vesication and ulceration, followed finally by resolution. Subsequently, a number of patients with localized solid tumours were treated by intermittent injection of small amounts of nitrogen mustard into the appropriate artery and some remarkable results recorded. Klopp also suggested methods by which the effects of therapy could be further intensified while systemic toxicity was reduced. For example, the tumour-bearing region could be isolated from the body and perfused with an artificial heart-lung machine; or a non-toxic antagonist to the agent could be given systemically at the same time as the intra-arterial injection. The first regional cancers treated by the isolation perfusion technique were reported eight years later by Creech et al. (1958) , and in the following 40 year Sullivan et al. (1959) described the treatment of patients with localized tumours by means of continuous intra-arterial infusion of supralethal doses of an antimetabolite together with intermittent, intramuscular injection of the specific metabolite, respectively methotrexate and folinic acid.
Regional cancer chemotherapy, as it may be called, has now been used in Westminster Hospital for exactly two years. We have thought it important to become familiar with all the main varieties of method in order that the most appropriate technique should be available for the particular clinical situation. As regards selection of cases for treatment, always a matter for radiotherapist and surgeon in consultation, we have been influenced on the one hand by our knowledge of the successes of radiation and surgery in customary combination, and on the other by the poor record of chemotherapy hitherto. For these reasons the majority of patients selected for intraarterial therapy had already been fully treated by standard methods, and cytotoxic agents were regarded as a last resort for palliation of recurrent or resistant disease.
Perfusion implies the continuous circulation of cytotoxic agents through a part, entering via the artery and leaving via the vein. Isolation of the region from the rest of the body may be achieved with varying degrees of completeness by means of a proximally placed tourniquet where possible, by occluding collateral vessels, and by influencing the arterial and venous pressures so that the respective gradients descend towards the perfused region. Extracorporeal perfusion is not well tolerated by the tissues for periods of more than an hour or so, therefore drugs must be used which will be effective with only relatively short periods of contact with the tumour. We have employed nitrogen mustard (HN2) and phenylalanine mustard (P.A.M.).
The perfusion apparatus comprises an arterial and venous pump, a disposable bubble oxygenator (Tables 1 & 2) . 10 patients had perfusions of the lower limb and one of the upper limb. In 1 patient with carcinoma of the breast the 'forequarter' was perfused via the subclavian vessels, a tourniquet being inflated round the upper arm. 2 patients received a perfusion of the hemipelvis for giant cell tumour of the ischium and spindle cell sarcoma of the buttock respectively. In both cases, as in the breast carcinoma, irradiation had failed to control the disease. We have not yet found any case of pelvic visceral disease suitable for perfusion. Of the miscellaneous group of tumours, which included in addition 2 soft-tissue sarcomas and 2 malignant bone tumours,only one patient showed a tumour reponse. This was the giant cell tumour of the pelvis which was controlled for six months, but the lesion subsequently resumed rapid growth.
The results in the malignant melanoma group have been more encouraging. In one patient multiple deposits in the lower limb have remained controlled for over a year. One patient showed complete regression in the perfused area for three months. Complete regression has been observed in a third, more recent, case. The first patient perfused two years ago with nitrogen mustard remains well and without clinical evidence of disease. Partial response was seen in 1 patient and in 2 cases perfusion was without effect.
There have been no vascular complications in the entire group, but 3 of the patients perfused with nitrogen mustard suffered severe peripheral nerve lesions: respectively, complete brachial plexus palsy, partial sciatic and femoral palsy, and partial femoral palsy.
The extracorporeal perfusion technique has been applied in some centres to the head and neck, but features of the local anatomy, for example the inaccessibility of the vertebral veins, involve a spillover which robs the method of its main advantage, and this territory seems more amenable to treatment by simpler regional methods. Again, complex and often severe procedures have been devised to perfuse the lung, liver and abdominal viscera. It would sometimes appear that enthusiasm for a new technique may impose a stress on the cancer patient disproportionate to the results which may reasonably be expected.
Our experience supports the conclusions of others in the United States and this country that uncontrolled malignant melanoma confined to a limb is at present the most rewarding lesion to subject to this treatment. We await with interest the results of trials elsewhere of perfusion in combination with surgery as primary treatment in early melanoma.
Regional infusion implies simply the administration of cytotoxic agents by continuous intraarterial drip. Any of the drug not fixed or inactivated by the tissues supplied by the first capillary bed returns to the patient through the veins. The appropriate vessel is cannulated with fine plastic tubing and the solution delivered either by means of a pump, or more usually in our hands by a gravity feed. Infusion may be continued for several weeks until maximal tumour response is obtained. Most courses are broken by Section ofRadiology one or more periods of intermission to allow recovery from depression of the white cell count or excessive local tissue toxicity.
Continuous infusion makes possible prolonged contact between drug and tumour and the method therefore lends itself to the application of the more gradually acting agents, e.g. certain antimetabolites. Our own experience in this field is confined almost entirely to methotrexate, an antifolic acid compound with which we have treated 50 patients (Table 3 ). In most instances we have employed the principle first practised by Sullivan of giving what he terms supralethal doses of methotrexate, e.g. 50 mg per day, the patient being protected from systemic toxicity by the simultaneous intramuscular injection of folinic acid (citrovorum factor). In 16 of the head and neck cases methotrexate has been infused intraarterially in ordinary doses, e.g. 4 mg/day without folinic acid cover. This modification has produced in general a much more intense local tissue reaction but the length of the course may be reduced owing to greater bone marrow depression.
Two primary bone tumours of the lower limb have been treated without effect. One was an osteogenic sarcoma of the femur, uncontrolled by radiotherapy and with pulmonary metastases. The other was a Ewing's tumour with lung deposits; the primary lesions had been unsuccessfully irradiated and perfused extracorporeally with nitrogen mustard. Of the 2 softtissue tumours in this region, both spindle cell fibrosarcomas, one was completely resistant to infusion but the other, in the upper part of the thigh, showed marked regression in size and complete relief of pain till the patient's death from pulmonary metastases five months later. The large bulk of a limb, especially the lower, to some extent detracts from the advantage in drug concentration which applies to intra-arterial therapy for smaller regions like the head and neck. Two carcinomas of the cervix have been treated, without success, by continuous methotrexate infusion into both internal iliac arteries cannulated at laparotomy. Two other patients were explored in whom the vessels were embedded in dense post-irradiation fibrous tissue and could not be exposed. This experience, and the limitations of the method reported by Trussell & Mitford- Barberton (1961) from Uganda in patients for whom no radiotherapy was available, suggest that, with the facilities at our disposal in this country, this particular technique has virtually no place in the management of uterine cervical cancer. Where regional chemotherapy is under consideration for palliation of pain and vaginal bleeding, simpler and less traumatic techniques exist. It is extremely important in this type of work to ensure that the tip of the cannula is accurately located. Arteriography is helpful but is time-consuming and, because the dye has to be injected forcibly, gives a picture which may be fallacious. A simple and accurate localizing device is the instillation of fluorescein, the area being viewed in ultraviolet light. The area treated is strictly limited by considerations of vascular anatomy and this, no doubt, accounts for Trussell's observation that, while the cervical growth often regressed dramatically, parametrial extension was least responsive.
Liver tumours, like those in the lung, pose a special problem because of the dual blood supply. One patient with a primary hepatoma was treated by infusion. At laparotomy one catheter was inserted into the gastroduodenal artery with its tip just short of the hepatic; a second catheter was tied into a jejunal vein. Angiography showed clearly that the tumour was supplied by the hepatic artery and this route was used for the infusion. This patient remains well one year later.
The majority of the 43 patients with head and neck tumours had squamous cell lesiors of the lip, tongue, tonsillar fossa, buccal mucosa and palate. Seven had growths of the antrum or ethmoid. Two had uncontrolled basal cell carcinomas of the face and there was one carcinoma arising in irradiated lupus vulgaris. There were 2 rhabdomyosarcomas, one of the mouth and one of the orbit, 1 adenocarcinoma of the parotid, and 1 fibrosarcoma in the region of the parotid in a 7i-year-old girl, our youngest patient. Five patients were infused twice and one on three occasions.
Most of the primary lesions in this series were situated within the territory of the external carotid artery. This vessel may be cannulated after exposure in the neck either directly through a stab incision in the artery wall, or via its lowest branch, the superior thyroid. Alternatively the external carotid may be entered retrogradely through the superficial temporal artery exposed in front of the pinna if this vessel is not too tortuous.
The cervical lymph nodes, except for the horizontal chain beneath the mandible, lie outside the treatment field and this is an unfortunate deficiency of the method. Not infrequently one sees excellent regression in the primary tumour, while the nodes remain unaltered. Again, for reasons of blood supply, lesions extending across the midline require bilateral infusion.
Elderly patients, who form a large proportion of these cases, do not tolerate well prolonged periods of confinement to bed and there is no reason why they should not enjoy limited mobility during the time of treatment.
Methotrexate in high concentration produces a mucosal effect very like the familiar irradiation film. This mucositis, although uncomfortable for the patient, is a desirable indication that a biological effect is being achieved and is as welcome a sight as the filming which accompanies a good radium needling.
Ocular and cerebral tumours derive their blood supply from the internal carotid artery. We are reluctant to employ continuous infusion in the case of this vessel or the common carotid because of the definite risk of thrombus formation and cerebral embolus. Intermittent injection is safer in these circumstances and, where possible, should be the method of choice if chemotherapy is being considered.
Twenty-seven patients have been treated by methotrexate with leucovorin (Table 4 ). The usual daily dose was 50 mg methotrexate and 24 mg folinic acid. The highest total dose of methotrexate was 812 mg and the longest overall infusion period one month. Sixteen patients received a course of methotrexate alone, usually 4 mg daily (Table 5 ). Six patients, 3 in each group, showed complete clinical regression of disease at the end of treatment, but 4 of these relapsed within three months. One patient only, a 67-year-old man with carcinoma of the palate, had a prolonged remission, being free from disease at the time of death from unrelated causes seven months after infusion.
In the entire series of 50 cases, 3 patients died from operative complications: massive pulmonary Complete regression 3 Partial regression 10 No regression 3 embolism, bronchopneumonia following cerebral thrombosis, and secondary hemorrhage from the common carotid artery. One other patient died from bronchopneumonia during the phase of bone marrow depression. The commonest complication was sepsis round the catheter, occasionally associated with a swinging fever resolving only when the catheter was withdrawn. Premature removal of the catheter was required on 7 occasions, and one patient accidentally pulled her own catheter out. Of 4 patients whose common or internal carotids were infused, 3 suffered hemiplegias, fortunately all transient.
In reviewing these cases we have been repeatedly disappointed by the observation that although initial tumour regression is the rule rather than the exception, all too often a residue of growth remains, even when the course has been prolonged. We believe that an important factor in this incompleteness of effect is the poverty of blood supply in a heavily irradiated area, the result of obliterative endarteritis. At the outset, we were reluctant to apply this untried method to the treatment of new cases, but we feel the time has now come to explore various combinations of chemotherapy with radiotherapy in the primary treatment of certain groups of patients, especially those with a poor prognosis. This type of approach, together with the widening range of drugs available, offers an exciting prospect to the clinician interested in the management of cancer.
